An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs

References

• Svalheim S, Sveberg L, Mochol M, et al. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12–17.
   PubMed Web of Science ®Google Scholar
• Herzog AG. A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy. Neurology. 1993;43(10):1907–1910.
   PubMed Web of Science ®Google Scholar
• Sahota P, Prabhakar S, Kharbanda PS, et al. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study. Epilepsia. 2008;49:2069–2077.
   PubMed Web of Science ®Google Scholar
• Arora E, Singh H, Gupta YK. Impact of antiepileptic drugs on bone health: need for monitoring, treatment, and prevention strategies. J Family Med Prim Care. 2016;5:248–253.
   PubMedGoogle Scholar
• Viswanathan LG, Satishchandra P, Bhimani BC, et al. Polycystic ovary syndrome in patients on antiepileptic drugs. Ann Indian Acad Neurol. 2016;19:339–343.
   PubMed Web of Science ®Google Scholar
• El Makawy AI, Ibrahim FM, Mabrouk DM, et al. Effect of antiepileptic drug (Topiramate) and cold pressed ginger oil on testicular genes expression, sexual hormones and histopathological alterations in mice. Biomed Pharmacother. 2019;110:409–419.
   PubMed Web of Science ®Google Scholar
• Wheeler MJ, Toone BK, Dannatt A, et al. Metabolic clearance rate of testosterone in male epileptic patients on anti-convulsant therapy. J Endocrinol. 1991;129:465–468.
   PubMed Web of Science ®Google Scholar
• Reimers A. New antiepileptic drugs and women. Seizure. 2014;23:585–591.
   PubMed Web of Science ®Google Scholar
• Khanna S, Pillai KK, Vohora D. Insights into liaison between antiepileptic drugs and bone. Drug Discov Today. 2009;14:428–435.
   PubMed Web of Science ®Google Scholar
• Kanda J, Izumo N, Kobayashi Y, et al. Effects of the antiepileptic drugs topiramate and lamotrigine on bone metabolism in rats. Biomed Res. 2017;38:297–305.
   PubMed Web of Science ®Google Scholar
• Voldby RG, Bajalan S. Atypical femoral fracture in a woman treated with lamotrigine. [Article in Danish]. Ugeskr Laeger. 2016;178:V09150705.
   PubMedGoogle Scholar
• El-Haggar SM, Mostafa TM, Allah HMS, et al. Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients. Arq Neuropsiquiatr. 2018;76:452–458.
   PubMed Web of Science ®Google Scholar
• Miziak B, Błaszczyk B, Chroscińska-Krawczyk M, et al. The problem of osteoporosis in epileptic patients taking antiepileptic drugs. Exp Opin Drug Saf. 2014;13:935–946.
   PubMed Web of Science ®Google Scholar
• Fan HC, Lee HS, Chang KP, et al. The impact of anti-epileptic drugs on growth and bone metabolism. Int J Mol Sci. 2016;17(8):E1242. .
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ, Randall A, et al. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology. 2008;70:1586–1593.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JW, Choi KG, et al. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav. 2007;10:291–295.
   PubMed Web of Science ®Google Scholar
• Lau KH, Nakade O, Barr B, et al. Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo. J Clin Endocrinol Metab. 1995;80:2347–2353.
   PubMed Web of Science ®Google Scholar
• Jetté N, Lix LM, Metge CJ, et al. Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol. 2011;68:107–112.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Coppola G, Parisi P, et al. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112:1–10.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Greco R, Morgese G, et al. Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol. 2000;47:385–388.
   PubMed Web of Science ®Google Scholar
• Schmitt BP, Nordlund DJ, Rodgers LA. Prevalence of hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy. J Fam Pract. 1984;18:873–877.
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004;45:1330–1337.
   PubMed Web of Science ®Google Scholar
• Fekete S, Simko J, Gradosova I, et al. The effect of levetiracetam on rat bone mass, structure and metabolism. Epilepsy Res. 2013;107:56–60.
   PubMed Web of Science ®Google Scholar
• Beniczky SA, Viken J, Jensen LT, et al. Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure. 2012;21:471–472.
   PubMed Web of Science ®Google Scholar
• Shiek Ahmad B, Hill KD, O’Brien TJ, et al. Falls and fractures in patients chronically treated with antiepileptic drugs. Neurology. 2012;79:145–151.
   PubMed Web of Science ®Google Scholar
• Dussault PM, Lazzari AA. Epilepsy and osteoporosis risk. Curr Opin Endocrinol Diabetes Obes. 2017;24:395–401.
   PubMed Web of Science ®Google Scholar
• Cho HH, Park HT, Kim YJ, et al. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem. 2005;96:533–542.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Greco R, Latini G, et al. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia. 2002;43:1488–1492.
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ, Marcus R, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol. 2005;57:252–257.
   PubMed Web of Science ®Google Scholar
• Petty SJ, O’Brien TJ, Wark JD. Anti-epileptic medication and bone health. Osteoporos Int. 2007;18:129–142.
   PubMed Web of Science ®Google Scholar
• Meier C, Kraenzlin ME. Antiepileptics and bone health. Ther Adv Musculoskelet Dis. 2011;3:235–243.
   PubMedGoogle Scholar
• Nakhaee Moghadam M, Teimouri A, Khajeh A. Bone metabolism disorder in epileptic children. Iran J Child Neurol. 2018;12:17–24.
   PubMed Web of Science ®Google Scholar
• Kanda J, Izumo N, Kobayashi Y, et al. Effects of the antiepileptic drugs phenytoin, gabapentin, and levetiracetam on bone strength, bone mass, and bone turnover in rats. Biol Pharm Bull. 2017;40:1934–1940.
   PubMed Web of Science ®Google Scholar
• Nulman I, Laslo D, Koren G. Treatment of epilepsy in pregnancy. Drugs. 1999;57:535–544.
   PubMed Web of Science ®Google Scholar
• Onodera K, Takahashi A, Sakurada S, et al. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sci. 2002;70:1533–1542.
   PubMed Web of Science ®Google Scholar
• Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000;289:1501–1504.
   PubMed Web of Science ®Google Scholar
• Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 2006;4:341–348.
   PubMed Web of Science ®Google Scholar
• Takeda S, Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone. 2008;42:837–840.
   PubMed Web of Science ®Google Scholar
• Apeland T, Mansoor MA, Strandjord RE. Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res. 2001;47:27–35.
   PubMed Web of Science ®Google Scholar
• Sharma TK, Vardey SK, Sitaraman S. Serum homocysteine, folate, and vitamin b12 levels in carbamazepine treated epileptic children. Clin Lab. 2016;62:1217–1224.
   PubMed Web of Science ®Google Scholar
• Kim DW, Lee SY, Shon YM, et al. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Epilepsia. 2013;54:e146–149.
   PubMed Web of Science ®Google Scholar
• Vacek TP, Kalani A, Voor MJ, et al. The role of homocysteine in bone remodeling. Clin Chem Lab Med. 2013;51:579–590.
   PubMed Web of Science ®Google Scholar
• Behera J, Bala J, Nuru M, et al. Homocysteine as a pathological biomarker for bone disease. J Cell Physiol. 2017;232:2704–2709.
   PubMed Web of Science ®Google Scholar
• Mahdavi A, Naeini AA, Najafi M, et al. Vitamin B12 and folate status in patients with epilepsy under levetiracetam monotherapy. Int J Prev Med. 2019;10:32.
   PubMed Web of Science ®Google Scholar
• Paknahad Z, Chitsaz A, Zadeh AH, et al. Effects of common anti-epileptic drugs on the serum levels of homocysteine and folic acid. Int J Prev Med. 2012;3(Suppl 1):S186–90.
   PubMedGoogle Scholar
• Simm PJ, Seah S, Gorelik A, et al. Impaired bone and muscle development in young people treated with antiepileptic drugs. Epilepsia. 2017;58(11):1931–1938.
   PubMed Web of Science ®Google Scholar
• Lee HS, Wang SY, Salter DM, et al. The impact of the use of antiepileptic drugs on the growth of children. BMC Pediatr. 2013;13:211.
   PubMed Web of Science ®Google Scholar
• Albaghdadi O, Alhalabi MS, Alourfi Z, et al. Bone health and vitamin D status in young epilepsy patients on valproate monotherapy. Clin Neurol Neurosurg. 2016;146:52–56.
   PubMed Web of Science ®Google Scholar
• Pitetzis DA, Spilioti MG, Yovos JG, et al. The effect of VPA on bone: from clinical studies to cell cultures-The molecular mechanisms revisited. Seizure. 2017;48:36–43.
   PubMed Web of Science ®Google Scholar
• Pack AM, Walczak TS. Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol. 2008;83:305–328.
   PubMed Web of Science ®Google Scholar
• Aksoy A, Sönmez FM, Deger O, et al. The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy. J Pediatr Endocrinol Metab. 2011;24:703–708.
   PubMed Web of Science ®Google Scholar
• Parveen B, Tiwari AK, Jain M, et al. The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats. Bone. 2018;113:57–67.
   PubMed Web of Science ®Google Scholar
• Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006;133:3231–3244.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1.
   PubMed Web of Science ®Google Scholar
• Almeida M, Han L, Bellido T, et al. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005;280:41342–41351.
   PubMed Web of Science ®Google Scholar
• Karner CM, Long F. Wnt signaling and cellular metabolism in osteoblasts. Cell Mol Life Sci. 2017;74:1649–1657.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang G, Gong L, et al. Isopsoralen regulates PPARγ/WNT to inhibit oxidative stress in osteoporosis. Mol Med Rep. 2018;17:1125–1131.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Y, Li S, et al. Wnt signaling pathway participates in valproic acid-induced neuronal differentiation of neural stem cells. Int J Clin Exp Pathol. 2015;8:578–585.
   PubMed Web of Science ®Google Scholar
• Parveen B, Tripathi M, Vohora D. A cross-sectional study to assess the modulation of Wnt inhibitors following anti-epileptic drug therapy and their correlation with vitamin D and receptor activator of nuclear factor κ B Ligand in Indian women with epilepsy. Basic Clin Pharmacol Toxicol. 2018;123:271–276.
   PubMed Web of Science ®Google Scholar
• Koo DL, Hwang KJ, Han SW, et al. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Epilepsy Res. 2014;108:442–447.
   PubMed Web of Science ®Google Scholar
• Aksoy D, Güveli BT1, Ak PD, et al. Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy. Clin Psychopharmacol Neurosci. 2016;14:74–78.
   PubMed Web of Science ®Google Scholar
• Vestergaard P. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs. 2015;17:141–150.
   PubMed Web of Science ®Google Scholar
• Lockau L, Atkinson SA. Vitamin D’s role in health and disease: how does the present inform our understanding of the past? Int J Paleopathol. 2018;23:6–14.
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Pizot C, et al. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2:76–89.
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey A, Gamble GD, et al. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;2:307–320.
   PubMed Web of Science ®Google Scholar
• Christakos S, Hewison M, Gardner DG, et al. Vitamin D: beyond bone. Ann N Y Acad Sci. 2013;1287:45–58.
   PubMed Web of Science ®Google Scholar
• Shellhaas RA, Joshi SM. Vitamin D and bone health among children with epilepsy. Pediatr Neurol. 2010;42(6):385–393.
   PubMed Web of Science ®Google Scholar
• Cebeci AN, Ekici B. Epilepsy treatment by sacrificing vitamin D. Expert Rev Neurother. 2014;14:481–491.
   PubMed Web of Science ®Google Scholar
• Saggese G, Vierucci F, Boot AM, et al. Vitamin D in childhood and adolescence: an expert position statement. Eur J Pediatr. 2015;174:565–576.
   PubMed Web of Science ®Google Scholar
• Harijan P, Khan A, Hussain N. Vitamin D deficiency in children with epilepsy: do we need to detect and treat it? J Pediatr Neurosci. 2013;8:5–10.
   PubMedGoogle Scholar
• Inaloo S, Paktinat M, Saki F, et al. Bone mineral density loss in ambulatory children with epilepsy in spite of using supplemental vitamin D in Southern Iran: a case-control study. J Bone Miner Metab. 2019;37:537–544.
   PubMed Web of Science ®Google Scholar
• Yildiz EP, Ş P, Bektas G, et al. Potential risk factors for vitamin D levels in medium- and long-term use of antiepileptic drugs in childhood. Acta Neurol Belg. 2017;117:447–453.
   PubMed Web of Science ®Google Scholar
• Bergqvist AG, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia. 2007;48:66–71.
   PubMed Web of Science ®Google Scholar
• Baek JH, Seo YH, Kim GH, et al. Vitamin D levels in children and adolescents with antiepileptic drug treatment. Yonsei Med J. 2014;55:417–421.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Park KM, Kim YM, et al. Longitudinal change of vitamin D status in children with epilepsy on antiepileptic drugs: prevalence and risk factors. Pediatr Neurol. 2015;52:153–159.
   PubMed Web of Science ®Google Scholar
• Tombini M, Palermo A, Assenza G, et al. Calcium metabolism serum markers in adult patients with epilepsy and the effect of vitamin D supplementation on seizure control. Seizure. 2018;58:75–81.
   PubMed Web of Science ®Google Scholar
• Sreedharan M, Devadathan K, Mohammed Kunju PA, et al. Vitamin D deficiency in ambulant children on carbamazepine or sodium valproate monotherapy. Indian Pediatr. 2018;55:307–310.
   PubMed Web of Science ®Google Scholar
• Shaikh AS, Guo X, Li Y, et al. The impact of antiepileptic drugs on vitamin levels in epileptic patients. Curr Pharm Biotechnol. 2018;19:674–681.
   PubMed Web of Science ®Google Scholar
• Nettekoven S, Ströhle A, Trunz B, et al. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr. 2008;167:1369–1377.
   PubMed Web of Science ®Google Scholar
• Souverein PC, Webb DJ, Weil JG, et al. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. 2006;66:1318–1324.
   PubMed Web of Science ®Google Scholar
• Viraraghavan VR, Seth A, Aneja S, et al. Effect of high dose vitamin d supplementation on vitamin d nutrition status of pre-pubertal children on anti-epileptic drugs - A randomized controlled trial. Clin Nutr ESPEN. 2019;29:36–40.
   PubMed Web of Science ®Google Scholar
• Fernandez H, Mohammed HT, Patel T. Vitamin D supplementation for bone health in adults with epilepsy: A systematic review. Epilepsia. 2018;59:885–896.
   PubMed Web of Science ®Google Scholar
• Offermann G, Pinto V, Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia. 1979;20:3–15.
   PubMed Web of Science ®Google Scholar
• Espinosa PS, Perez DL, Abner E, et al. Association of antiepileptic drugs, vitamin D, and calcium supplementation with bone fracture occurrence in epilepsy patients. Clin Neurol Neurosurg. 2011;113:548–551.
   PubMed Web of Science ®Google Scholar
• Momeni SN, Masoud SA, Banafshe HR. Inhibitory effects of chronic administration of vitamin D3 on pentylenetetrazole-induced seizures in mice. Epilepsy Res. 2019;149:76–82.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Morawska M, Furmanek-Karwowska K, et al. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur J Pharmacol. 2007;573:111–115.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Morawska D, Morawska M. Effect of cholecalciferol on the anticonvulsant action of some second generation antiepileptic drugs in the mouse model of maximal electroshock. Pharmacol Rep. 2015;67:875–880.
   PubMed Web of Science ®Google Scholar
• Şahin S, Gürgen SG, Yazar U, et al. Vitamin D protects against hippocampal apoptosis related with seizures induced by kainic acid and pentylenetetrazol in rats. Epilepsy Res. 2019;149:107–116.
   PubMed Web of Science ®Google Scholar
• Takahaski K, Onodera A. Valproic acid induced osteopenia and its prevention with alfacalcidol andalendronate. J HardTissue Biol. 2005;14:275–276.
   Google Scholar
• Khanna S, Pillai KK, Vohora D. Bisphosphonates in phenytoin-induced bone disorder. Bone. 2011;48:597–606.
   PubMed Web of Science ®Google Scholar
• Lazzari AA, Dussault PM, Thakore-James M, et al. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy–antiepileptic drug and osteoporosis prevention trial. Epilepsia. 2013;54:1997–2004.
   PubMed Web of Science ®Google Scholar
• Mimata Y, Sato K, Oikawa R, et al. Non- traumatic thoracic vertebral compression fractures occurred in a young epileptic patient: a case report. J Orthop Case Rep. 2016;6:85–87.
   PubMedGoogle Scholar
• Lovato C, Lewicki EM. Emerging anabolic agents in the treatment of osteoporosis. Expert Opin Emerg Drugs. 2017;22:247–257.
   PubMed Web of Science ®Google Scholar
• Awasthi H, Mani D, Singh D, et al. The underlying pathophysiology and therapeutic approaches for osteoporosis. Med Res Rev. 2018;38:2024–2057.
   PubMed Web of Science ®Google Scholar
• Banach M, Popławska M, Błaszczyk B, et al. Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities. Expert Opin Drug Metab Toxicol. 2016;12:1067–1080.
   PubMed Web of Science ®Google Scholar
• Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord. 2017;208:56–61.
   PubMed Web of Science ®Google Scholar
• Lee SH, Mastronardi CA, Li RW, et al. Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats. Transl Psychiatry. 2019;9:10.
   PubMed Web of Science ®Google Scholar
• Rabenda V, Nicolet D, Beaudart C, et al. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int. 2013;24:121–137.
   PubMed Web of Science ®Google Scholar
• Eom CS, Lee HK, Ye S, et al. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. J Bone Miner Res. 2012;27:1186–1195.
   PubMed Web of Science ®Google Scholar
• Wadhwa R, Kumar M, Talegaonkar S, et al. Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms. Osteoporos Sarcopenia. 2017;3:75–81.
   PubMedGoogle Scholar
• Gebara MA, Shea ML, Lipsey KL, et al. Depression, antidepressants, and bone health in older adults: a systematic review. J Am Geriatr Soc. 2014;62:1434–1441.
   PubMed Web of Science ®Google Scholar
• Ortuño MJ, Robinson ST, Subramanyam P, et al. Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. Nat Med. 2016;22:1170–1179.
   PubMed Web of Science ®Google Scholar
• Lappe J, Watson P, Travers-Gustafson D, et al. Effect of vitamin d and calcium supplementation on cancer incidence in older women: a randomized clinical trial. Jama. 2017;317:1234–1243.
   PubMed Web of Science ®Google Scholar
• Tao MH, Dai Q, Chen S, et al. Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women’s Health Initiative. Lung Cancer. 2017;110:42–47.
   PubMed Web of Science ®Google Scholar
• Hant FN, Bolster MB. Drugs that may harm bone: mitigating the risk. Cleve Clin J Med. 2016;83:281–288.
   PubMed Web of Science ®Google Scholar
• Peacock A, Mattick RP, Bruno R. A review of caffeine use as a risk or protective factor for women’s health and pregnancy. Curr Opin Psychiatry. 2017;30:253–259.
   PubMed Web of Science ®Google Scholar
• Chrościńska-Krawczyk M, Radzik I, Miziak B, et al. Safety considerations for patients with epilepsy taking antiepileptic drugs alongside caffeine or other methylxanthine derivatives. Expert Opin Drug Metab Toxicol. 2014;10:981–989.
   PubMed Web of Science ®Google Scholar
• Ghadimi R, Hosseini SR, Asefi S, et al. Influence of smoking on bone mineral density in elderly men. Int J Prev Med. 2018;9:111.
   PubMed Web of Science ®Google Scholar
• Czuczwar M, Kiś J, Czuczwar P, et al. Nicotine diminishes anticonvulsant activity of antiepileptic drugs in mice. Pol J Pharmacol. 2003;55:799–802.
   PubMedGoogle Scholar
• Anwar MJ, Radhakrishna KV, Sharma A, et al. Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-β3 content in bone of female mice. Eur J Pharm Sci. 2014;62:219–226.
   PubMed Web of Science ®Google Scholar